SCHEMBL7035609

SCHEMBL7035609

CC(c1ccccc1)n1c(=O)[nH]c2nc[nH]c2c1=O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 7/20 0.52
▸ ADORA2A P29274 4/20 0.52
▸ ADORA3 P0DMS8 6/20 0.52
▸ PDE4A P27815 3/20 0.49
▸ PDE4B Q07343 3/20 0.49
▸ PDE4C Q08493 3/20 0.49
▸ PDE4D Q08499 3/20 0.49
▸ FYN P06241 1/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ USP1 O94782 1/20 0.41
▸ MET P08581 1/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2B6 P20813 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2793746 0.86 ADORA2B (0.54) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL12413533 0.81 ADORA2B (0.63) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL8750704 0.79 ADORA2B (0.50) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL150602 0.79 ADORA2B (0.59) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL897035 0.75 ADORA2B (0.55) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL2917584 0.75 ADORA2B (0.55) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL10535015 0.74 ADORA2A (0.57) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL6952184 0.74 SLC2A1 (0.41) ADORA2BADORA3MAPK1LMNASMN1; SMN2
SCHEMBL481336 0.73 FYN (0.50) FYNMAPK1USP1METCYP3A4
SCHEMBL481335 0.73 FYN (0.50) FYNMAPK1USP1METCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444233-A2 A 2B? ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2004-08-11 — — EP disclosed
WO-2003042214-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2003-05-22 — — WO disclosed
Send feedback